You are here:
» Topical valrubicin application reduces skin inflammation ...
About Aarhus University
Topical valrubicin application reduces skin inflammation in murine models
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
- E Hauge
- Helle Christiansen, Denmark
- C Rosada, Denmark
- E de Darkó ,
- T N Dam, Denmark
- K Stenderup
Valrubicin is a cytostatic anthracycline analogue, lacking toxicity by skin and tissue contact, and represents a new drug with potential for topical treatment of psoriasis and nonmelanoma skin cancer (NMSC); the beneficial effects have been partly explained by its antiproliferative and proapoptotic characteristics.
| Original language | English |
|---|---|
| Journal | British Journal of Dermatology |
| Volume | 167 |
| Issue | 2 |
| Pages (from-to) | 288-95 |
| Number of pages | 8 |
| ISSN | 0007-0963 |
| DOIs | |
| Publication status | Published - 2012 |
- Acute Disease, Administration, Cutaneous, Animals, Anti-Inflammatory Agents, Chronic Disease, Cytokines, Dermatitis, Irritant, Disease Models, Animal, Doxorubicin, Irritants, Mice, Mice, Inbred C57BL, Neutrophil Infiltration, Tetradecanoylphorbol Acetate
Research areas
See relations at Aarhus University Citationformats
ID: 52852434